Modulation of intracellular signaling

Details for Australian Patent Application No. 2011223563 (hide)

Owner ANGSTROM PHARMACEUTICALS, INC.

Inventors Finlayson, Malcolm; Damaj, Bassam B.

Agent Griffith Hack

Pub. Number AU-A-2011223563

PCT Pub. Number WO2011/109678

Priority 61/311,214 05.03.10 US

Filing date 4 March 2011

Wipo publication date 9 September 2011

International Classifications

A61K 38/00 Medicinal preparations containing peptides

G01N 33/48 Investigating or analysing materials by specific methods not covered by groups - Biological material, e.g. blood, urine

Event Publications

1 November 2012 PCT application entered the National Phase

  PCT publication WO2011/109678 Priority application(s): WO2011/109678

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011223566-Substituted aza-bicyclic imidazole derivatives useful as TRPM8 receptor modulators

2011223560-Process for the preparation of 2-(cyclohexylmethyl)-N-{2- [(2S)-1-methylpyrrolidin-2-yl]ethyl}-1, 2, 3, 4tetrahydroisoquinoline-7-sulfonamide